CompanyDeals

Silence Therapeutics Receives $4 Million Milestone Payment from Hansoh Pharmaceutical

Company

Harbour BioMed Reports First-Ever Profit in H1 2023 Interim Financial Results

CompanyDeals

InnoCare Pharma and ArriVent Biopharma Partner on SHP2 Inhibitor and EGFR Inhibitor Combination

CompanyDrug

GSK’s Cabotegravir Receives NMPA Approval for HIV Treatment in China

CompanyMedical Device

Beijing Tinavi Medical’s Knee Replacement Navigation System Approved by NMPA

CompanyDeals

GeneQuantum Healthcare and Aimed Bio Expand Partnership to Develop Five Novel ADC Drugs

CompanyDrug

BeiGene’s Brukinsa Receives US FDA Review for Relapsed/Refractory Follicular Lymphoma sNDA

CompanyDrug

AstraZeneca and Daiichi Sankyo’s Enhertu Gains New Indication Approval in China for HER2-Low Breast Cancer

CompanyPolicy / Regulatory

US FDA Approves Additional Shipments of Qilu Pharmaceutical’s Cisplatin to Address Shortage

CompanyDrug

Shanghai Fosun Pharmaceutical Submits Tenapanor Approval Application to China’s NMPA

CompanyDeals

DNE Group Launches $485 Million Fund for Life Sciences Park in Shanghai Pudong

CompanyDeals

LianBio Secures Clinical Supply Agreement with AstraZeneca for SHP2 Inhibitor Trial